Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
Clinical trial NCT04252742 · COMPLETED
Trial details
- NCT number
- NCT04252742
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2023-10-26
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.